A potent, broadly neutralizing human monoclonal antibody that efficiently protects hACE2-transgenic mice from infection with the Wuhan, BA.5, and XBB.1.5 SARS-CoV-2 variants › Research Explorer

DOI

https://doi.org/10.3389/fimmu.2024.1442160
Final published version

Konstantin O. Baranov
Sergey V. Kulemzin
Tatyana N. Belovezhets
Anton N. Chikaev
Svetlana V. Murasheva
Olga Y. Volkova
Alexander M. Najakshin
Nikolai A. Chikaev
Pavel P. Solodkov
Maria V. Sergeeva
Alexander V. Smirnov
Irina A. Serova
Alexander G. Markhaev
Yulia V. Kononova
Alexander Y. Alekseev
Daria M. Danilenko
Alexander M. Shestopalov
Alexander V. Taranin

Original language	English
Article number	1442160
Number of pages	8
Journal	Frontiers in Immunology
Volume	15
DOIs	https://doi.org/10.3389/fimmu.2024.1442160
Publication status	Published - 9 Aug 2024

OECD FOS+WOS

3.01.NI IMMUNOLOGY

Research areas

COVID-19, Omicron, SARS-CoV-1, iC1 antibody, in vivo protection

ID: 61205436